Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Pozycja w akcjach #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Cena akcji
$0.001
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$5.88K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
400.00%
Kraj
US
Handel MetaStat Inc (MTST)

Kategoria

Historia ceny akcji dla MetaStat Inc (MTST)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $8.64K dnia 2009-01-01
Historia cen akcji firmy MetaStat Inc od 2009 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 463.64%
2024 0.00%
2023 0.00%
2022 -94.49%
2021 -97.16%
2020 -66.02%
2019 -80.17%
2018 -86.53%
2017 -59.23%
2016 -66.02%
2015 -30.12%
2014 -67.24%
2013 -59.82%
2012 145.63%
2011 -91.79%
2010 111.42%
2009 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$57.26 50.14%
CN
$108.57 62.31%
CH
$460.07 28.69%
IE
$287.89 109.53%
US
$8.79 84.34%
TH